BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17390588)

  • 1. Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes.
    Ohshiro T; Rudel LL; Omura S; Tomoda H
    J Antibiot (Tokyo); 2007 Jan; 60(1):43-51. PubMed ID: 17390588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA:cholesterol acyltransferase 2 isozyme.
    Ohshiro T; Ohte S; Matsuda D; Ohtawa M; Nagamitsu T; Sunazuka T; Harigaya Y; Rudel LL; Omura S; Tomoda H
    J Antibiot (Tokyo); 2008 Aug; 61(8):503-8. PubMed ID: 18997389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.
    Tomoda H; Doi T
    Acc Chem Res; 2008 Jan; 41(1):32-9. PubMed ID: 17803269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selectivity of beauveriolide derivatives in inhibition toward the two isozymes of acyl-CoA: cholesterol acyltransferase.
    Ohshiro T; Matsuda D; Nagai K; Doi T; Sunazuka T; Takahashi T; Rudel LL; Omura S; Tomoda H
    Chem Pharm Bull (Tokyo); 2009 Apr; 57(4):377-81. PubMed ID: 19336931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of acyl-CoA:cholesterol acyltransferase 2 isozyme by flavasperone and sterigmatocystin from Aspergillus species.
    Sakai K; Ohte S; Ohshiro T; Matsuda D; Masuma R; Rudel LL; Tomoda H
    J Antibiot (Tokyo); 2008 Sep; 61(9):568-72. PubMed ID: 19160525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New verticilides, inhibitors of acyl-CoA:cholesterol acyltransferase, produced by Verticillium sp. FKI-2679.
    Ohshiro T; Matsuda D; Kazuhiro T; Uchida R; Nonaka K; Masuma R; Tomoda H
    J Antibiot (Tokyo); 2012 May; 65(5):255-62. PubMed ID: 22415459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoform-specific inhibitors of ACATs: recent advances and promising developments.
    Ohshiro T; Tomoda H
    Future Med Chem; 2011 Dec; 3(16):2039-61. PubMed ID: 22098352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages.
    Namatame I; Tomoda H; Ishibashi S; Omura S
    Proc Natl Acad Sci U S A; 2004 Jan; 101(3):737-42. PubMed ID: 14718664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness.
    Lada AT; Davis M; Kent C; Chapman J; Tomoda H; Omura S; Rudel LL
    J Lipid Res; 2004 Feb; 45(2):378-86. PubMed ID: 14617738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 1.
    Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Omura S; Tomoda H; Nagamitsu T
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1285-7. PubMed ID: 23369538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular target of rubimaillin in the inhibition of lipid droplet accumulation in macrophages.
    Matsuda D; Ohshiro T; Ohba M; Jiang W; Hong B; Si S; Tomoda H
    Biol Pharm Bull; 2009 Aug; 32(8):1317-20. PubMed ID: 19652367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 3.
    Ohtawa M; Yamazaki H; Ohte S; Matsuda D; Ohshiro T; Rudel LL; Ōmura S; Tomoda H; Nagamitsu T
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3798-801. PubMed ID: 23711919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver.
    Parini P; Davis M; Lada AT; Erickson SK; Wright TL; Gustafsson U; Sahlin S; Einarsson C; Eriksson M; Angelin B; Tomoda H; Omura S; Willingham MC; Rudel LL
    Circulation; 2004 Oct; 110(14):2017-23. PubMed ID: 15451793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of simple, yet potent and selective non-ring-A pyripyropene A-based inhibitors of acyl-coenzyme A: cholesterol acyltransferase 2 (ACAT2).
    Zhan Y; Zhang XW; Xiong Y; Li BL; Nan FJ
    Org Biomol Chem; 2016 Jan; 14(2):747-751. PubMed ID: 26584338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical modification and structure-activity relationships of pyripyropenes. 3. Synthetic conversion of pyridine-pyrone moiety.
    Obata R; Sunazuka T; Tian Z; Tomoda H; Harigaya Y; Omura S
    J Antibiot (Tokyo); 1997 Mar; 50(3):229-36. PubMed ID: 9127194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical role for the histidine residues in the catalytic function of acyl-CoA:cholesterol acyltransferase catalysis: evidence for catalytic difference between ACAT1 and ACAT2.
    An S; Cho KH; Lee WS; Lee JO; Paik YK; Jeong TS
    FEBS Lett; 2006 May; 580(11):2741-9. PubMed ID: 16647063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentacecilides, new inhibitors of lipid droplet formation in mouse macrophages, produced by Penicillium cecidicola FKI-3765-1: I. Taxonomy, fermentation, isolation and biological properties.
    Yamazaki H; Kobayashi K; Matsuda D; Nonaka K; Masuma R; Omura S; Tomoda H
    J Antibiot (Tokyo); 2009 Apr; 62(4):195-200. PubMed ID: 19300470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyripyropene A, an acyl-coenzyme A:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemia.
    Ohshiro T; Matsuda D; Sakai K; Degirolamo C; Yagyu H; Rudel LL; Omura S; Ishibashi S; Tomoda H
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1108-15. PubMed ID: 21393580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penicillium griseofulvum F1959, high-production strain of pyripyropene a, specific inhibitor of acyl-CoA: cholesterol acyltransferase 2.
    Choi JH; Rho MC; Lee SW; Choi JN; Lee HJ; Bae KS; Kim K; Kim YK
    J Microbiol Biotechnol; 2008 Oct; 18(10):1663-5. PubMed ID: 18955816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of acyl-CoA cholesterol acyltransferase by F12511 (Eflucimibe): could it be a new antiatherosclerotic therapeutic?
    López-Farré AJ; Sacristán D; Zamorano-León JJ; San-Martín N; Macaya C
    Cardiovasc Ther; 2008; 26(1):65-74. PubMed ID: 18466422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.